Jason Krikorian - 13 Jul 2024 Form 4 Insider Report for Augmedix, Inc.

Role: Director
Signature: /s/ Todd Holvick, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 13 Jul 2024
Net transactions value: $0
Form type: 4
Filing time: 15 Jul 2024, 21:59:28 UTC
Previous filing: 12 Jun 2024
Next filing: 15 Aug 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	AUGX	Common Stock	Options Exercise		+21,598	+41%		74,230	13 Jul 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	AUGX	Restricted Stock Units	Options Exercise	$0	-21,598	-100%	$0.000000^*	0	13 Jul 2024	Common Stock	21,598		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2	On July 13, 2023 (the "Grant Date"), the reporting person was granted 21,598 RSUs which vested in full on the one-year anniversary of the Grant Date.